Key Business Metrics: Q4 20231 Revenue: up +8.3% to $9Bn (vs. $9Bn expected) Adjusted diluted EPS: up +12.2% to $1.36 (vs. $1.45 expected) Total volume: down -0.5% to 185.1Bn (HnB volume: +6.1% to 34Bn) Oral nicotine shipment volume: +23.4% to 219.6Mn cans Smoke-free revenue: up +13.6% to $3.6Bn => 39.3%...
BAT: FY23 Results
Top-line1 - Revenue: £27.28Bn (vs. £27.9Bn expected) - Reported Revenue: down -1.3%, largely due to the sale of Russian business as well as the impact of lower cigarette volume (mainly in the US) and a translational FX headwind of 2.9% (due to the relative strength of £, particularly against the...

